<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03406143</url>
  </required_header>
  <id_info>
    <org_study_id>CGFskin</org_study_id>
    <nct_id>NCT03406143</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration</brief_title>
  <official_title>Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluating whether autologous Concentrate Growth Factors(CGF)
      is safe and/or effective to accelerating skin regeneration and soft tissue expansion.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">August 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Measure the Change in Inflation Volume of the Silicone Expander From Baseline at 8 Weeks</measure>
    <time_frame>baseline and 8 weeks post treatment</time_frame>
    <description>Record the inflation volume(ml) of each expander with the maintained inner pressure. The inflation volume was recorded according to the injection volume during expansion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To Measure the Texture of Expanded Flap With Canfield's Visia Scanner</measure>
    <time_frame>baseline and 8 weeks post treatment</time_frame>
    <description>Evaluate skin texture with Canfield's Visia skin analysis imaging system and compare the characteristics including RBX red, RBX brown, pores, spots, et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of Major Adverse Events</measure>
    <time_frame>Up to approximately 24 months after study start</time_frame>
    <description>Including expanded flap ischaemia, necrosis, fluidify, infection, and all other adverse events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Scar</condition>
  <arm_group>
    <arm_group_label>CGF injection group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Concentrate Growth Factors(CGF) will be harvested through centrifugation afte intravenous blood collection. Venous blood was collected in tube and then centrifuged in Medifuge system（Thermo Scientific）. About 2ml liquid CGF can be harvested from 9ml venous blood. Patients will receive autologous CGF injection subdermally to expanded skin at the density of 0.02 ml/cm2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>0.9% saline will be injected into expanded skin for control study. Patients will receive saline injection subdermally to expanded skin at the density of 0.02 ml/cm2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CGF injection</intervention_name>
    <description>CGF injection subdermally to expanded skin at the density of 0.02ml/cm2.</description>
    <arm_group_label>CGF injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Saline will be injected into expanded skin</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 14 to 65 years;

          -  Expanding skin donor site at the face, neck, anterior chest wall, abdominal wall or
             back;

          -  Persistent high level of expander internal pressure;

          -  Need for further skin expansion;

        Exclusion Criteria:

          -  • Not fit for soft tissue expansion treatment;

               -  Evidence of infection, ischemia, ulcer or other pathological changes within the
                  targeting area which defined as not suitable for expansion; or history of delayed
                  healing, radiational therapy;

               -  Significant renal, cardiovascular, hepatic and psychiatric diseases;

               -  Significant medical diseases or infection (including but not limited to the
                  carrier of hepatitis B virus or HIV)

               -  BMI &gt;30;

               -  History of any hematological disease, including leukopenia , thrombocytopenia, or
                  thrombocytosis;

               -  History of allogenic bone marrow transplantation;

               -  Long history of smoking;

               -  Evidence of malignant diseases or unwillingness to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital, Affliated to Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Qing Feng, MD; PhD</last_name>
      <phone>0086 21 63089567</phone>
      <email>dr.liqingfeng@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Chen Cheng, MD</last_name>
      <phone>0086 21 13621925833</phone>
      <email>shno9hospital@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Li Qingfeng, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xie Yun, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cheng chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qing-Feng Li, M.D., Ph.D.</last_name>
      <phone>86 21 23271699</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2017</study_first_submitted>
  <study_first_submitted_qc>January 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Qing-FengLi Li,MD</investigator_full_name>
    <investigator_title>M.D., Ph.D.,Head of PRS Department</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

